BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 1999
View Archived Issues
Caspase inhibition by Ac-YVAD-cmk enhances nigral transplant survival
Read More
Phase III results support use of memantine in dementia
Read More
Cerebral metabolic consequences of NOS deficiency in null mice
Read More
Cardiovascular and Renal Drugs Advisory Committee will discuss Betapace at April meeting
Read More
Pharmacological profile of A-216546, a novel endothelin antagonist
Read More
Novartis discusses short-term pipeline at annual press conference
Read More
Licensing opportunity from NIH: infectious papillomavirus pseudoviral particles
Read More
Shaman refines restructuring process, maintains new focus on botanical products
Read More
Biovector collaborates with Chiron and Bayer on DNA delivery applications
Read More
Structural Bioinformatics achieves research milestone
Read More
Clinical trials begin for IFN-alpha gene therapy in cancer patients
Read More
SciClone receives additional Zadaxin marketing approvals in Singapore and Vietnam
Read More
Plant-produced cancer vaccine enables mice to survive non-Hodgkin's lymphoma
Read More
Warner-Lambert patents new series of irreversible TK inhibitors
Read More
uPA-uPAR antagonists in development at Roche for tumors and tumor metastasis
Read More
RCT reports synthesis of novel antibiotics active against resistant pathogens
Read More
Pfizer discloses selective hydroxamic acid-based MMP-13 inhibitors
Read More
Kynurenine pathway enzyme inhibitors from P&U for neuropathological disorders
Read More
Pediatric clinical trials of exisulind expanded; analysis of phase III adult trial data continues
Read More
Licensing opportunity from Yeda: vanadyl ion carriers for the treatment of diabetes
Read More
Genzyme Transgenics and Millennium BioTherapeutics collaborate on transgenic biotherapeutics
Read More
Antex Chlamydia vaccine shows promise in animal study
Read More
Gliatech initiates new R&D program for antiinflammatory MAbs
Read More
Arsenous acid for relapsed APL under evaluation in China
Read More
Vion seeks permission to begin clinical trials of TAPET vectors
Read More
Further marketing authorizations granted in Europe for Muse
Read More
CPMP supports new labeling, new indication and new strength of Gonal-F
Read More
Japanese market clearance obtained for Casodex 80
Read More
Preliminary InTIME-II results point to equivalence of lanoteplase and alteplase in AMI
Read More